Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma

The role of imaging in the management of adults with diffuse low grade glioma

(2015) Sarah Jost Fouke et al.   JOURNAL OF NEURO-ONCOLOGY

Effects of flip angle uncertainty and noise on the accuracy of DCE-MRI metrics: comparison between standard concentration-based and signal difference methods

(2015) Ping Wang et al.   MAGNETIC RESONANCE IMAGING

Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas

(2015) Francesca Piludu et al.   NEURORADIOLOGY

DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma

(2014) K.E. Shin et al.   CLINICAL RADIOLOGY

Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab

(2014) Philipp Kickingereder et al.   JOURNAL OF NEURO-ONCOLOGY

MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy

(2014) Shahrzad Jalali et al.   NEURO-ONCOLOGY

Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

(2013) B. M. Ellingson et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts

(2013) Siver A. Moestue et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy

(2013) Kyung Ah Kim et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media

(2013) Clemens C. Cyran et al.   CANCER IMAGING

Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: A preclinical study of cervical carcinoma and melanoma xenografts

(2012) Kirsti Marie Øvrebø et al.   ACTA ONCOLOGICA

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

(2012) S De Bruyne et al.   BRITISH JOURNAL OF CANCER

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

(2012) M J Paldino et al.   BRITISH JOURNAL OF RADIOLOGY

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

(2012) Whitney B. Pope et al.   JOURNAL OF NEURO-ONCOLOGY

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

(2011) W.B. Pope et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis

(2011) Aytekin Oto et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

(2011) John F. de Groot et al.   JOURNAL OF CLINICAL ONCOLOGY

Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil

(2011) Chao-Yu Hsu et al.   JOURNAL OF HEPATOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

(2009) A. Craig Lockhart et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiangiogenic strategies for treatment of malignant gliomas

(2009) Andrew S. Chi et al.   Neurotherapeutics

Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions

(2008) Edward Ashton et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Contribution of the apparent diffusion coefficient in perilesional edema for the assessment of brain tumors

(2008) R. Guzman et al.   JOURNAL OF NEURORADIOLOGY

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE